Calamos Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $105M | Buy |
483,670
+17,380
| +4% | +$3.86M | 0.37% | 50 |
|
|
2025
Q4 | $107M | Buy |
466,290
+15,458
| +3% | +$3.52M | 0.4% | 43 |
|
|
2025
Q3 | $104M | Sell |
450,832
-19,186
| -4% | -$3.91M | 0.39% | 45 |
|
|
2025
Q2 | $87.2M | Sell |
470,018
-31,743
| -6% | -$5.9M | 0.34% | 56 |
|
|
2025
Q1 | $105M | Buy |
501,761
+58,470
| +13% | +$11.4M | 0.46% | 37 |
|
|
2024
Q4 | $78.8M | Buy |
443,291
+517
| +0.1% | +$95.1K | 0.33% | 57 |
|
|
2024
Q3 | $87.4M | Sell |
442,774
-6,730
| -1% | -$1.26M | 0.38% | 49 |
|
|
2024
Q2 | $77.1M | Sell |
449,504
-11,105
| -2% | -$1.84M | 0.34% | 54 |
|
|
2024
Q1 | $83.9M | Sell |
460,609
-7,859
| -2% | -$1.35M | 0.4% | 48 |
|
|
2023
Q4 | $72.6M | Sell |
468,468
-3,918
| -0.8% | -$571K | 0.35% | 62 |
|
|
2023
Q3 | $70.4M | Buy |
472,386
+578
| +0.1% | +$84.9K | 0.37% | 54 |
|
|
2023
Q2 | $63.6M | Sell |
471,808
-194
| -0% | -$28.4K | 0.31% | 69 |
|
|
2023
Q1 | $75.2M | Sell |
472,002
-43,633
| -8% | -$6.67M | 0.37% | 55 |
|
|
2022
Q4 | $83.3M | Sell |
515,635
-69,387
| -12% | -$10.6M | 0.39% | 50 |
|
|
2022
Q3 | $78.5M | Sell |
585,022
-60,958
| -9% | -$8.75M | 0.36% | 49 |
|
|
2022
Q2 | $98.9M | Buy |
645,980
+12,694
| +2% | +$1.94M | 0.43% | 35 |
|
|
2022
Q1 | $103M | Buy |
633,286
+86,633
| +16% | +$12.6M | 0.39% | 40 |
|
|
2021
Q4 | $74M | Buy |
546,653
+15,202
| +3% | +$1.8M | 0.28% | 82 |
|
|
2021
Q3 | $57.3M | Buy |
531,451
+62,014
| +13% | +$7.09M | 0.25% | 96 |
|
|
2021
Q2 | $52.9M | Buy |
469,437
+203,536
| +77% | +$22.9M | 0.24% | 98 |
|
|
2021
Q1 | $28.8M | Buy |
265,901
+8,107
| +3% | +$867K | 0.16% | 157 |
|
|
2020
Q4 | $27.6M | Sell |
257,794
-11,420
| -4% | -$1.1M | 0.16% | 159 |
|
|
2020
Q3 | $23.6M | Sell |
269,214
-23,594
| -8% | -$2.22M | 0.15% | 168 |
|
|
2020
Q2 | $28.7M | Buy |
292,808
+34,714
| +13% | +$3.06M | 0.2% | 138 |
|
|
2020
Q1 | $19.7M | Sell |
258,094
-25,124
| -9% | -$2.14M | 0.15% | 185 |
|
|
2019
Q4 | $25.1M | Sell |
283,218
-3,146
| -1% | -$261K | 0.12% | 211 |
|
|
2019
Q3 | $21.7M | Buy |
286,364
+26,601
| +10% | +$1.82M | 0.12% | 222 |
|
|
2019
Q2 | $18.9M | Sell |
259,763
-8,748
| -3% | -$688K | 0.1% | 236 |
|
|
2019
Q1 | $21.6M | Sell |
268,511
-378,020
| -58% | -$30.9M | 0.14% | 211 |
|
|
2018
Q4 | $59.6M | Sell |
646,531
-36,057
| -5% | -$3.17M | 0.39% | 67 |
|
|
2018
Q3 | $64.6M | Sell |
682,588
-82,726
| -11% | -$7.84M | 0.36% | 65 |
|
|
2018
Q2 | $70.9M | Sell |
765,314
-361,697
| -32% | -$35.3M | 0.43% | 47 |
|
|
2018
Q1 | $107M | Buy |
1,127,011
+266,165
| +31% | +$29.2M | 0.69% | 23 |
|
|
2017
Q4 | $83.3M | Buy |
860,846
+657,967
| +324% | +$62M | 0.42% | 33 |
|
|
2017
Q3 | $18M | Buy |
202,879
+6,803
| +3% | +$518K | 0.14% | 210 |
|
|
2017
Q2 | $14.2M | Sell |
196,076
-44,653
| -19% | -$3M | 0.11% | 242 |
|
|
2017
Q1 | $15.7M | Sell |
240,729
-964
| -0.4% | -$60.6K | 0.12% | 223 |
|
|
2016
Q4 | $15.1M | Sell |
241,693
-2,903
| -1% | -$177K | 0.12% | 204 |
|
|
2016
Q3 | $15.4M | Sell |
244,596
-312,391
| -56% | -$20.2M | 0.11% | 221 |
|
|
2016
Q2 | $34.5M | Sell |
556,987
-1,138,822
| -67% | -$69.4M | 0.24% | 134 |
|
|
2016
Q1 | $96.9M | Buy |
1,695,809
+346,879
| +26% | +$19.3M | 0.64% | 30 |
|
|
2015
Q4 | $79.9M | Buy |
1,348,930
+429,912
| +47% | +$24.8M | 0.51% | 45 |
|
|
2015
Q3 | $50M | Buy |
919,018
+688,784
| +299% | +$44.8M | 0.34% | 90 |
|
|
2015
Q2 | $15.5M | Sell |
230,234
-11,848
| -5% | -$773K | 0.1% | 220 |
|
|
2015
Q1 | $14.2M | Sell |
242,082
-15,583
| -6% | -$941K | 0.09% | 227 |
|
|
2014
Q4 | $16.9M | Buy |
257,665
+13,565
| +6% | +$855K | 0.11% | 205 |
|
|
2014
Q3 | $14.1M | Hold |
244,100
| – | – | 0.09% | 215 |
|
|
2014
Q2 | $13.8M | Buy |
244,100
+16,300
| +7% | +$855K | 0.09% | 215 |
|
|
2014
Q1 | $11.7M | Hold |
227,800
| – | – | 0.07% | 228 |
|
|
2013
Q4 | $12M | Hold |
227,800
| – | – | 0.08% | 222 |
|
|
2013
Q3 | $10.2M | Hold |
227,800
| – | – | 0.06% | 239 |
|
|
2013
Q2 | $9.42M | Buy |
+227,800
| New | +$9.96M | 0.06% | 226 |
|
Other funds holding ABBV
VCM
VPM
Calamos Advisors's ABBV Position: Q1 2026 in Review
Calamos Advisors increased its AbbVie (ABBV) stake by 3.7% in Q1 2026, buying an estimated $3.86M and bringing the position to 483,670 shares worth $105M. The position accounts for 0.37% of the portfolio, ranked #50.
Calamos Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $107M in Q1 2018. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Calamos Advisors held 483,670 shares of AbbVie worth $105M as of Q1 2026.
- Calamos Advisors bought 17,380 AbbVie shares in Q1 2026, an estimated $3.86M.
- AbbVie made up 0.37% of Calamos Advisors's portfolio in Q1 2026, its #50 holding.
- Calamos Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Calamos Advisors's AbbVie position peaked at $107M in Q1 2018.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.